Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Hypertrophy, Right Ventricular D017380 4 associated lipids
Brain Injuries D001930 4 associated lipids
Hepatitis B, Chronic D019694 4 associated lipids
Lymphoma, T-Cell, Cutaneous D016410 4 associated lipids
Milk Hypersensitivity D016269 4 associated lipids
Liver Failure D017093 5 associated lipids
Neoplastic Cells, Circulating D009360 5 associated lipids
Hepatitis, Alcoholic D006519 5 associated lipids
Granulomatosis with Polyangiitis D014890 5 associated lipids
Osteonecrosis D010020 5 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Kerek M et al. Effects of recombinant platelet activating factor acetylhydrolase in obstructive jaundice. 2003 Jul-Aug Hepatogastroenterology pmid:12845989
Nomikos TN et al. Acetyl-CoA:1-O-alkyl-sn-glycero-3-phosphocholine acetyltransferase (lyso-PAF AT) activity in cortical and medullary human renal tissue. 2003 Eur. J. Biochem. pmid:12846832
Suzuki M et al. Actin assembly is a crucial factor for superoxide anion generation from adherent human eosinophils. 2003 J. Allergy Clin. Immunol. pmid:12847489
Talvani A et al. Experimental Trypanosoma cruzi infection in platelet-activating factor receptor-deficient mice. 2003 Microbes Infect. pmid:12850205
Desquand S et al. Interference of BN 52021, an antagonist of PAF, with different forms of active anaphylaxis in the guinea-pig: importance of the booster injection. 1991 Br. J. Pharmacol. pmid:1285397
Taggart DP et al. Neuroprotection during cardiac surgery: a randomised trial of a platelet activating factor antagonist. 2003 Heart pmid:12860868
Takafuji S et al. Matrix metalloproteinase-9 release from human leukocytes. 2003 J Investig Allergol Clin Immunol pmid:12861851
Bar-Or D et al. Copper stimulates the synthesis and release of interleukin-8 in human endothelial cells: a possible early role in systemic inflammatory responses. 2003 Shock pmid:12865660
Kujiraoka T et al. Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus. 2003 J. Lipid Res. pmid:12867534
D'Andrea D et al. Induction of tissue factor in the arterial wall during recurrent thrombus formation. 2003 Arterioscler. Thromb. Vasc. Biol. pmid:12869352
Lupia E et al. The membrane attack complex of complement contributes to plasmin-induced synthesis of platelet-activating factor by endothelial cells and neutrophils. 2003 Immunology pmid:12871223
Kuo RY et al. Antiplatelet activity of benzylisoquinoline derivatives oxidized by cerium(IV) ammonium nitrate. 2003 Bioorg. Med. Chem. Lett. pmid:12873516
Yang Y et al. Kupffer cells are a major source of increased platelet activating factor in the CCl4-induced cirrhotic rat liver. 2003 J. Hepatol. pmid:12873816
Biffl WL et al. Clinically relevant hypertonicity prevents stored blood- and lipid-mediated delayed neutrophil apoptosis independent of p38 MAPK or caspase-3 activation. 2003 Surgery pmid:12874587
Fukuoka T et al. [Experimental study on platelet activating factor and systemic circulatory failure caused by ischemic liver]. 1992 Nihon Geka Gakkai Zasshi pmid:1287460
Vernadakis A et al. Role of astrocytes in aging: late passage primary mouse brain astrocytes and C-6 glial cells as models. 1992 Prog. Brain Res. pmid:1287725
Akisu M et al. Selective head cooling with hypothermia suppresses the generation of platelet-activating factor in cerebrospinal fluid of newborn infants with perinatal asphyxia. 2003 Prostaglandins Leukot. Essent. Fatty Acids pmid:12878450
Bourgain RH et al. PAF-acether induced arterial thrombosis and the effect of specific antagonists. 1992 Adv. Exp. Med. Biol. pmid:1288104
Møller CH and Steinbrüchel DA Platelet function after coronary artery bypass grafting: is there a procoagulant activity after off-pump compared with on-pump surgery? 2003 Scand. Cardiovasc. J. pmid:12881156
Lupia E et al. Intra-plaque production of platelet-activating factor correlates with neoangiogenesis in human carotid atherosclerotic lesions. 2003 Int. J. Mol. Med. pmid:12883648
Handa RK et al. Role of Nitric oxide in the renal and systemic vasodilatory responses to platelet-activating factor in the rat, in vivo. 2003 Kidney Blood Press. Res. pmid:12886044
Curry FE et al. Thrombin increases permeability only in venules exposed to inflammatory conditions. 2003 Am. J. Physiol. Heart Circ. Physiol. pmid:12893636
Mayer K et al. Omega-3 vs. omega-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation. 2003 Intensive Care Med pmid:12897994
Shen Z et al. Effects of plumbagin on platelet aggregation and platelet-neutrophil interactions. 2003 Planta Med. pmid:12898414
de Assis EF et al. Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytes. 2003 J. Immunol. pmid:12902515
Hu H et al. Glycoprotein IIb/IIIa inhibition attenuates platelet-activating factor-induced platelet activation by reducing protein kinase C activity. 2003 J. Thromb. Haemost. pmid:12911597
Kalia N and Bardhan KD Of blood and guts: association between Helicobacter pylori and the gastric microcirculation. 2003 J. Gastroenterol. Hepatol. pmid:12911655
Tokuoka SM et al. Involvement of platelet-activating factor and LIS1 in neuronal migration. 2003 Eur. J. Neurosci. pmid:12911752
Lie WJ et al. Regulation and kinetics of platelet-activating factor and leukotriene C4 synthesis by activated human basophils. 2003 Clin. Exp. Allergy pmid:12911788
Nakatsuka M et al. Platelet activating factor in culture media as an indicator of human embryonic development after in-vitro fertilization. 1992 Hum. Reprod. pmid:1291573
Mano T et al. Novel imidazole compounds as a new series of potent, orally active inhibitors of 5-lipoxygenase. 2003 Bioorg. Med. Chem. pmid:12927848
Kald B et al. Platelet-activating factor (PAF-acether) formation in neonatal intestinal mucosa and in cultured intestinal epithelial cells. 1992 Eur Surg Res pmid:1292936
Abete P et al. Age-related effects of platelet activating factor (PAF) in the isolated perfused rat heart. 1992 J. Mol. Cell. Cardiol. pmid:1293314
Guarino MP et al. PAF-like lipids- and PAF-induced gallbladder muscle contraction is mediated by different pathways in guinea pigs. 2003 Am. J. Physiol. Gastrointest. Liver Physiol. pmid:12936911
Tomaszewska R et al. Platelet activating factor (PAF) inhibitor (TCV-309) reduces caerulein- and PAF-induced pancreatitis. A morphologic and functional study in the rat. 1992 J. Physiol. Pharmacol. pmid:1294265
Izquierdo I et al. Rupatadine: a new selective histamine H1 receptor and platelet-activating factor (PAF) antagonist. A review of pharmacological profile and clinical management of allergic rhinitis. 2003 Drugs Today pmid:12944997
Zhu L et al. Internalization of caveolin-1 scaffolding domain facilitated by Antennapedia homeodomain attenuates PAF-induced increase in microvessel permeability. 2004 Am. J. Physiol. Heart Circ. Physiol. pmid:12946927
Benelli R et al. Neutrophils and angiogenesis: potential initiators of the angiogenic cascade. 2003 Chem Immunol Allergy pmid:12947984
Shinozaki K et al. Species differences in platelet aggregation induced by platelet-activating factor (PAF). 1992 Methods Find Exp Clin Pharmacol pmid:1294855
Liu J et al. Lipopolysaccharide induces anandamide synthesis in macrophages via CD14/MAPK/phosphoinositide 3-kinase/NF-kappaB independently of platelet-activating factor. 2003 J. Biol. Chem. pmid:12949078
Wierzbicki T et al. IL-4 primes human endothelial cells for secondary responses to histamine. 2003 J. Leukoc. Biol. pmid:12949246
Gabrijelcic J et al. Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression. 2003 Eur. Respir. J. pmid:12952263
Perales J et al. Neutralization of the oedematogenic activity of Bothrops jararaca venom on the mouse paw by an antibothropic fraction isolated from opossum (Didelphis marsupialis) serum. 1992 Agents Actions pmid:1295374
McDonagh PF et al. Chronic expression of platelet adhesion proteins is associated with severe ischemic heart disease in type 2 diabetic patients: Chronic platelet activation in diabetic heart patients. 2003 Sep-Oct J. Diabetes Complicat. pmid:12954156
Armenaka M and Rosenstreich DL The pathophysiology of chronic urticaria. 1992 Clin Rev Allergy pmid:1295690
Krause S et al. Defective function of blood granulocytes in patients with diabetes mellitus-associated marginal periodontitis. 1992 Folia Biol. (Praha) pmid:1295773
Bayar MA et al. The effect of EGb-761 on morphologic vasospasm in canine basilar artery after subarachnoid hemorrhage. 2003 J. Cardiovasc. Pharmacol. pmid:12960685
Kato M et al. The role of platelet activating factor and the efficacy of apafant ophthalmic solution in experimental allergic conjunctivitis. 2003 J Ocul Pharmacol Ther pmid:12964956
Ishiura Y et al. Airway eosinophil accumulation on sensory neuropeptide release in a guinea pig model of distilled-water-induced bronchoconstriction. 2003 J Investig Allergol Clin Immunol pmid:12968390
Calabresi L et al. Endothelial protection by high-density lipoproteins: from bench to bedside. 2003 Arterioscler. Thromb. Vasc. Biol. pmid:12969988
Zhao XY et al. [Effects of BIO-1211 on eosinophil chemotaxis, recruitment and mediator release]. 2003 Zhejiang Da Xue Xue Bao Yi Xue Ban pmid:12970925
Lamparter E and Lunkenheimer CH The automation of dissolution testing of solid oral dosage forms. 1992 Oct-Dec J Pharm Biomed Anal pmid:1298375
Cheng NN et al. [The composition of phospholipid and biosynthesis of platelet-activating factor in earthworm (Eisenia foetida)]. 1992 Yao Xue Xue Bao pmid:1299136
Wong B et al. Identification of a membrane-associated 1-0-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine hydrolyzing phospholipase A2 in guinea pig 1 epidermis. Implications in the cutaneous biosynthesis of platelet-activating factor. 1992 FEBS Lett. pmid:1299618
Wu QX [Amplification and desensitization in platelet activation]. 1992 Sheng Li Ke Xue Jin Zhan pmid:1299958
Doly M et al. Inhibition of vincristine-induced retinal impairments by a specific PAF antagonist. 1992 Lens Eye Toxic Res pmid:1301801
Nijkamp FP et al. Reversal of the endotoxin-induced bronchial hyperreactivity to histamine by the platelet activating factor antagonist BN 52021. 1992 Pneumonol Alergol Pol pmid:1305483
Hirano T and Manabe T "Cocktail" therapy for acute pancreatitis: combined therapy of protease inhibitor, xanthine oxidase inhibitor and platelet activating factor antagonist in rat caerulein-induced pancreatis. 1992 Nihon Geka Hokan pmid:1306981
Li Q [Effects of inhaled aerosol of platelet activating factor on pulmonary function and airway responsiveness in normal subjects]. 1992 Zhonghua Jie He He Hu Xi Za Zhi pmid:1307517
Klöcking HP Inhibition of PAF-induced tPA release by KO-286011. 1992 Ann. N. Y. Acad. Sci. pmid:1309038
Zoratti EM et al. Platelet-activating factor primes human eosinophil generation of superoxide. 1992 Am. J. Respir. Cell Mol. Biol. pmid:1309421
van Willigen G and Akkerman JW Regulation of glycoprotein IIB/IIIA exposure on platelets stimulated with alpha-thrombin. 1992 Blood pmid:1309427
Bratton DL et al. The mechanism of internalization of platelet-activating factor in activated human neutrophils. Enhanced transbilayer movement across the plasma membrane. 1992 J. Immunol. pmid:1309560
Ono S and Voelkel NF PAF receptor blockade inhibits lung vascular changes in the rat monocrotaline model. 1992 Lung pmid:1310128
Schwaner I et al. Receptor-mediated increases in cytosolic Ca2+ in the human erythroleukaemia cell line involve pertussis toxin-sensitive and -insensitive pathways. 1992 Biochem. J. pmid:1310589
Gandhi CR et al. A comparative study of endothelin- and platelet-activating-factor-mediated signal transduction and prostaglandin synthesis in rat Kupffer cells. 1992 Biochem. J. pmid:1310601
Jagels MA and Hugli TE Neutrophil chemotactic factors promote leukocytosis. A common mechanism for cellular recruitment from bone marrow. 1992 J. Immunol. pmid:1310708
Földes-Filep E et al. C-reactive protein inhibits intracellular calcium mobilization and superoxide production by guinea pig alveolar macrophages. 1992 J. Leukoc. Biol. pmid:1311010
Yue TL et al. Platelet-activating factor stimulates phosphoinositide turnover in neurohybrid NCB-20 cells: involvement of pertussis toxin-sensitive guanine nucleotide-binding proteins and inhibition by protein kinase C. 1992 Mol. Pharmacol. pmid:1311408
Grandoni KM et al. Trichothecene mycotoxins inhibit phosphoinositide hydrolysis in bovine platelets stimulated with platelet activating factor. 1992 Toxicology pmid:1311467
Wu T et al. Endothelin-1 stimulates eicosanoid production in cultured human nasal mucosa. 1992 Am. J. Respir. Cell Mol. Biol. pmid:1311593
Catalán RE et al. PAF-induced activation of polyphosphoinositide-hydrolyzing phospholipase C in cerebral cortex. 1992 Biochem. Biophys. Res. Commun. pmid:1311925
Shukla SD Platelet-activating factor receptor and signal transduction mechanisms. 1992 FASEB J. pmid:1312046
Aepfelbacher M et al. Bacterial lipopolysaccharide up-regulates platelet-activating factor-stimulated Ca2+ mobilization and eicosanoid release in human Mono Mac 6 cells. 1992 J. Immunol. pmid:1312103
Henson PM et al. NHLBI workshop summary. Platelet-activating factor: role in pulmonary injury and dysfunction and blood abnormalities. 1992 Am. Rev. Respir. Dis. pmid:1312316
Alonso MT et al. Effects of the antithrombitic agent PCA 4230 on agonist-induced Ca2+ entry and Ca2+ release in human platelets. 1992 Biochim. Biophys. Acta pmid:1312357
Bazan NG Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor. 2003 J. Lipid Res. pmid:13130128
Chatterjee SS et al. Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators. 2003 Pharmacopsychiatry pmid:13130392
e Silva PM et al. Nedocromil sodium prevents in vivo generation of the eosinophilotactic substance induced by PAF but fails to antagonize its effects. 1992 Br. J. Pharmacol. pmid:1313729
Schaberg T et al. Superoxide anion release induced by platelet-activating factor is increased in human alveolar macrophages from smokers. 1992 Eur. Respir. J. pmid:1314191
Zhu YP et al. The presence of platelet-activating factor binding sites in human myometrium and their role in uterine contraction. 1992 Am. J. Obstet. Gynecol. pmid:1314480
Rabinovici R et al. Platelet activating factor mediates interleukin-2-induced lung injury in the rat. 1992 J. Clin. Invest. pmid:1314853
Zarco P et al. Involvement of platelet-activating factor and tumour necrosis factor in the pathogenesis of joint inflammation in rabbits. 1992 Clin. Exp. Immunol. pmid:1315229
Kuijpers TW et al. Neutrophil migration across monolayers of cytokine-prestimulated endothelial cells: a role for platelet-activating factor and IL-8. 1992 J. Cell Biol. pmid:1315317
Carveth HJ et al. Regulation of platelet-activating factor (PAF) synthesis and PAF-mediated neutrophil adhesion to endothelial cells activated by thrombin. 1992 Semin. Thromb. Hemost. pmid:1315452
Adler KB et al. Platelet-activating factor provokes release of mucin-like glycoproteins from guinea pig respiratory epithelial cells via a lipoxygenase-dependent mechanism. 1992 Am. J. Respir. Cell Mol. Biol. pmid:1316134
Morland CM et al. Selective eosinophil leukocyte recruitment by transendothelial migration and not by leukocyte-endothelial cell adhesion. 1992 Am. J. Respir. Cell Mol. Biol. pmid:1316135
Koltai M et al. Role of PAF and cytokines in microvascular tissue injury. 1992 J. Lab. Clin. Med. pmid:1316420
Fukuchi Y et al. Low ligand binding activities of two distinct types of Fc gamma receptor on guinea-pig peripheral blood polymorphonuclear leukocytes are differentially improved by proteolysis or platelet activating factor. 1992 Mol. Immunol. pmid:1316550
Sehmi R et al. Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. 1992 Blood pmid:1316789
Pinckard RN et al. Differential responsiveness of human neutrophils to the autocrine actions of 1-O-alkyl-homologs and 1-acyl analogs of platelet-activating factor. 1992 J. Immunol. pmid:1316919
Kimura K et al. Different preparations of zymosan induce glycogenolysis independently in the perfused rat liver. Involvement of mannose receptors, peptide-leukotrienes and prostaglandins. 1992 Biochem. J. pmid:1317164
Joly F et al. Biosynthesis of paf-acether in cultured-mouse mast cells: the role of calcium and G proteins. 1992 Biochem. Biophys. Res. Commun. pmid:1317174
Moreira-Ludewig R and Healy CT A rapid microtiter plate method for the detection of lysozyme release from human neutrophils. 1992 J Pharmacol Toxicol Methods pmid:1317227
Smith LJ Bioactive mediators in asthma. 1992 Chest pmid:1317278
Graham RM et al. Plasma platelet-activating factor degradation in patients with severe coronary artery disease. 1992 Clin. Sci. pmid:1317763
Guinn DE et al. Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonists. 1992 J. Med. Chem. pmid:1317924
Herbert JM Characterization of specific binding sites of 3H-labelled platelet-activating factor ([3H]PAF) and a new antagonist, [3H]SR 27417, on guinea-pig tracheal epithelial cells. 1992 Biochem. J. pmid:1318021
Hidi R et al. Formation of LTB4 by fMLP-stimulated alveolar macrophages accounts for eosinophil migration in vitro. 1992 J. Leukoc. Biol. pmid:1318347
Rediske JJ et al. Platelet activating factor stimulates intracellular calcium transients in human neutrophils: involvement of endogenous 5-lipoxygenase products. 1992 J. Leukoc. Biol. pmid:1318349